Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratnadeep Basu

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cardiovascular Research|February 3, 2011
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunitSreedhar Bodiga, Jiu Chang Zhong, Wang Wang, et al.
Scientific Reports|December 8, 2015
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapySubhash K Das, Wang Wang, Pavel Zhabyeyev, et al.
Diabetes|November 26, 2009
Human recombinant ACE2 reduces the progression of diabetic nephropathyGavin Y Oudit, George C Liu, Jiuchang Zhong, et al.
Journal of the American Heart Association|July 3, 2013
Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analoguesWang Wang, Shaun M K McKinnie, Vaibhav B Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2019
Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogsWang Wang, Mengcheng Shen, Conrad Fischer, et al.
Nature Communications|December 21, 2018
PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart diseaseVaibhav B Patel, Pavel Zhabyeyev, Xueyi Chen, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cardiovascular Research|February 3, 2011
Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunitSreedhar Bodiga, Jiu Chang Zhong, Wang Wang, et al.
Scientific Reports|December 8, 2015
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapySubhash K Das, Wang Wang, Pavel Zhabyeyev, et al.
Diabetes|November 26, 2009
Human recombinant ACE2 reduces the progression of diabetic nephropathyGavin Y Oudit, George C Liu, Jiuchang Zhong, et al.
Journal of the American Heart Association|July 3, 2013
Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analoguesWang Wang, Shaun M K McKinnie, Vaibhav B Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2019
Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogsWang Wang, Mengcheng Shen, Conrad Fischer, et al.
Nature Communications|December 21, 2018
PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart diseaseVaibhav B Patel, Pavel Zhabyeyev, Xueyi Chen, et al.
Pageof 5